Cargando…

Is local review of positron emission tomography scans sufficient in diffuse large B‐cell lymphoma clinical trials? A CALGB 50303 analysis

BACKGROUND: Quantitative methods of Fluorodeoxyglucose Positron Emission Tomography (FDG‐PET) interpretation, including the percent change in FDG uptake from baseline (ΔSUV), are under investigation in lymphoma to overcome challenges associated with visual scoring systems (VSS) such as the Deauville...

Descripción completa

Detalles Bibliográficos
Autores principales:	Torka, Pallawi, Pederson, Levi D., Knopp, Michael V., Poon, David, Zhang, Jun, Kahl, Brad S., Higley, Howard R., Kelloff, Gary, Friedberg, Jonathan W., Schwartz, Lawrence H., Wilson, Wyndham H., Leonard, John P., Bartlett, Nancy L., Schöder, Heiko, Ruppert, Amy S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	BRIEF COMMUNICATION
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10134372/ https://www.ncbi.nlm.nih.gov/pubmed/36799072 http://dx.doi.org/10.1002/cam4.5628

Ejemplares similares

The prognostic significance of PFS24 in follicular lymphoma following firstline immunotherapy: A combined analysis of 3 CALGB trials
por: Lansigan, Frederick, et al.
Publicado: (2018)

Outcomes of a Modified CALGB 19802 Regimen in Adult Acute Lymphoblastic Leukemia
por: Han, A-Reum, et al.
Publicado: (2008)

Diabetes and Clinical Outcome in Patients With Metastatic Colorectal Cancer: CALGB 80405 (Alliance)
por: Brown, Justin C, et al.
Publicado: (2019)

Sugar-Sweetened Beverage Intake and Cancer Recurrence and Survival in CALGB 89803 (Alliance)
por: Fuchs, Michael A., et al.
Publicado: (2014)

Race, Income, and Survival in Stage III Colon Cancer: CALGB 89803 (Alliance)
por: Lee, Seohyuk, et al.
Publicado: (2021)

Phase II study of the farnesyltransferase inhibitor R115777 in advanced melanoma (CALGB 500104)
por: Gajewski, Thomas F, et al.
Publicado: (2012)

Body Mass Index and Weight Loss in Metastatic Colorectal Cancer in CALGB (Alliance)/SWOG 80405
por: Guercio, Brendan J, et al.
Publicado: (2020)

Current directions in the treatment of classical Hodgkin lymphoma
por: Keller, Frank G., et al.
Publicado: (2023)

Treatment of adult Burkitt lymphoma with the CALGB 1002 protocol: a single center experience in Jordan
por: Ma’koseh, Mohammad, et al.
Publicado: (2021)

A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central America
por: Rangel-Patiño, Juan, et al.
Publicado: (2023)

Positron emission tomography and magnetic resonance imaging in primary central nervous system lymphoma—a narrative review
por: Krebs, Simone, et al.
Publicado: (2021)

Prognostic factors for adult patients with Burkitt lymphoma treated with dose-adjusted EPOCH-R
por: Lakhotia, Rahul, et al.
Publicado: (2023)

IGF-Binding Proteins, Adiponectin, and Survival in Metastatic Colorectal Cancer: Results From CALGB (Alliance)/SWOG 80405
por: Guercio, Brendan J, et al.
Publicado: (2020)

Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance)
por: Fadelu, Temidayo, et al.
Publicado: (2018)

Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance)
por: Brown, Justin C, et al.
Publicado: (2018)

Geriatric assessment for older adults receiving less-intensive therapy for acute myeloid leukemia: report of CALGB 361101
por: Ritchie, Ellen K., et al.
Publicado: (2022)

Molecular subtypes of breast cancer in relation to paclitaxel response and outcomes in women with metastatic disease: results from CALGB 9342
por: Harris, Lyndsay N, et al.
Publicado: (2006)

Polygenic Inheritance of Paclitaxel-Induced Sensory Peripheral Neuropathy Driven by Axon Outgrowth Gene Sets in CALGB 40101 (Alliance)
por: Chhibber, Aparna, et al.
Publicado: (2014)

Blood‐based markers of efficacy and resistance to cetuximab treatment in metastatic colorectal cancer: results from CALGB 80203 (Alliance)
por: Hatch, Ace J., et al.
Publicado: (2016)

The impact of early PEG-asparaginase discontinuation in young adults with ALL: a post hoc analysis of the CALGB 10403 study
por: Aldoss, Ibrahim, et al.
Publicado: (2022)

CAR T-cell therapy has comparable efficacy with autologous transplantation in older adults with DLBCL in partial response
por: Akhtar, Othman S., et al.
Publicado: (2023)

Long‐term trajectories of self‐reported cognitive function in a cohort of older survivors of breast cancer: CALGB 369901 (Alliance)
por: Mandelblatt, Jeanne S., et al.
Publicado: (2016)

Genomic landscape of patients with FLT3-mutated acute myeloid leukemia (AML) treated within the CALGB 10603/RATIFY trial
por: Jahn, Nikolaus, et al.
Publicado: (2022)

Pevonedistat, a NEDD8‐activating enzyme inhibitor, induces apoptosis and augments efficacy of chemotherapy and small molecule inhibitors in pre‐clinical models of diffuse large B‐cell lymphoma
por: Torka, Pallawi, et al.
Publicado: (2020)

Metformin sensitizes therapeutic agents and improves outcome in pre-clinical and clinical diffuse large B-cell lymphoma
por: Singh, Anil R., et al.
Publicado: (2020)

Measuring Disease-Free Survival and Cancer Relapse Using Medicare Claims From CALGB Breast Cancer Trial Participants (Companion to 9344)
por: Lamont, Elizabeth B., et al.
Publicado: (2006)

A Molecular Model for Predicting Overall Survival in Patients with Metastatic Clear Cell Renal Carcinoma: Results from CALGB 90206 (Alliance)
por: Kim, Hyung L., et al.
Publicado: (2015)

Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance)
por: Guercio, Brendan J., et al.
Publicado: (2018)

Assessing the Impact of CALGB 9343 on Surgical Trends in Elderly-Women With Stage I ER+ Breast Cancer: A SEER-Based Analysis
por: Bazan, Jose G., et al.
Publicado: (2019)

Marital Status, Living Arrangement, and Cancer Recurrence and Survival in Patients with Stage III Colon Cancer: Findings from CALGB 89803 (Alliance)
por: Lee, Seohyuk, et al.
Publicado: (2022)

Immunological and clinicopathological features predict HER2-positive breast cancer prognosis in the neoadjuvant NeoALTTO and CALGB 40601 randomized trials
por: Rediti, Mattia, et al.
Publicado: (2023)

Prostate-specific membrane antigen positron emission tomography (PSMA-PET) for local staging of prostate cancer: a systematic review and meta-analysis
por: Woo, Sungmin, et al.
Publicado: (2020)

Economic evaluation study (CHEER-compliant): Cost-effectiveness analysis of RAS screening for treatment of metastatic colorectal cancer based on the CALGB 80405 trial
por: Zhou, Jing, et al.
Publicado: (2016)

Pretreatment vitamin D level and response to neoadjuvant chemotherapy in women with breast cancer on the I-SPY trial (CALGB 150007/150015/ACRIN6657)
por: Clark, Amy S, et al.
Publicado: (2014)

Multimodality imaging using proton magnetic resonance spectroscopic imaging and (18)F-fluorodeoxyglucose-positron emission tomography in local prostate cancer
por: Shukla-Dave, Amita, et al.
Publicado: (2017)

Are Scientists Sufficiently Ambitious?
por: Petersen, Ole H
Publicado: (2022)

From Sufficient Health to Sufficient Responsibility
por: Davies, Ben, et al.
Publicado: (2020)

Virtual reality hip arthroscopy simulator demonstrates sufficient face validity
por: Bartlett, Jonathan D., et al.
Publicado: (2018)

CALGB 40603 (Alliance): Long-Term Outcomes and Genomic Correlates of Response and Survival After Neoadjuvant Chemotherapy With or Without Carboplatin and Bevacizumab in Triple-Negative Breast Cancer
por: Shepherd, Jonathan H., et al.
Publicado: (2022)

Randomisierte Phase-II-Studie zur an der PET-Response orientierten multimodalen Therapie des Speiseröhrenkrebses – Ergebnisse des CALGB 80803 (Alliance) Trial
por: Bauer, Lukas, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u3h4aa3i223hegeemvbsllm4aq